Johnson & Johnson (JNJ) Change in Cash (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Change in Cash came in at $2.0 billion in Q1 2026, down 86.23% year-on-year from $14.4 billion in Q1 2025, and up 33.9% quarter-over-quarter from $1.5 billion in Q4 2025.

Johnson & Johnson (JNJ) Change in Cash (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Change in Cash across 18 years of filings, most recently posting $2.0 billion for Q1 2026.

  • Change in Cash for Q1 2026 came in at $2.0 billion, down 86.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.8 billion (down 229.11% YoY), and the FY2025 annual result was -$4.4 billion, down 295.73% from the prior year.
  • Change in Cash came in at $2.0 billion for Q1 2026 at Johnson & Johnson, up from $1.5 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $14.4 billion in Q1 2025 to a low of -$19.9 billion in Q2 2025.
  • The 5-year median for Change in Cash is -$346.0 million (2025), against an average of -$29.5 million.
  • Across the five-year window, Change in Cash surged 416.55% in 2023 and sank 3244.03% in 2025, its largest moves.
  • Johnson & Johnson's Change in Cash stood at -$4.0 billion in 2022, then jumped by 152.96% to $2.1 billion in 2023, then surged by 93.57% to $4.1 billion in 2024, then slumped by 64.17% to $1.5 billion in 2025, then surged by 33.9% to $2.0 billion in 2026.
  • The last three Change in Cash figures came in at $2.0 billion (Q1 2026), $1.5 billion (Q4 2025), and -$346.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn -71.45 Mn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn -1.99 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 1.98 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn 4.16 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn -9.29 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 65.00 Mn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn 563.00 Mn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -635.00 Mn
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 1.98 Bn
Dec 28, 2025 1.48 Bn
Sep 28, 2025 -346.00 Mn
Jun 29, 2025 -19.90 Bn
Mar 30, 2025 14.37 Bn
Dec 29, 2024 4.13 Bn
Sep 29, 2024 -4.90 Bn
Jun 30, 2024 -595.00 Mn
Mar 31, 2024 3.61 Bn
Dec 31, 2023 2.13 Bn
Oct 1, 2023 -1.46 Bn
Jul 2, 2023 -5.68 Bn
Apr 2, 2023 12.74 Bn
Jan 1, 2023 -3.98 Bn
Apr 3, 2022 -4.02 Bn
Oct 3, 2021 3.27 Bn
Jul 4, 2021 1.66 Bn
Apr 4, 2021 -1.31 Bn
Jan 3, 2021 -4.98 Bn
Sep 27, 2020 7.79 Bn